Infervision is an AI technology company which untilizes deep learning technology to assist physicians with medical image diagnosis.
Location: United States, Pennsylvania, Philadelphia
Employees: 201-500
Total raised: $186M
Founded date: 2015
Investors 5
| Date | Name | Website |
| - | Genesis Ca... | gcfunds.co... |
| - | New Allian... | nac-capita... |
| - | Xiang He C... | xianghecap... |
| - | Qiming Ven... | qimingvent... |
| - | Qiming Ven... | qimingvc.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 23.07.2021 | Series D | $139M | - |
| 19.03.2018 | - | $47M | - |
Mentions in press and media 14
| Date | Title | Description |
| 10.07.2026 | Medical AI Ecosystem Innovation Forum and iMedLoop Global Medical Imaging Data Platform Launch Held in Beijing | When Healthcare Meets AI: A New Era of Ecosystem-wide Innovation Is Accelerating BEIJING, July 10, 2026 /PRNewswire/ -- On July 4, the Medical AI Ecosystem Innovation Forum and iMedLoop Global Medical Imaging Data Platform Launch was held i... |
| 16.08.2021 | InferVision AI Assists the European Commission Monitoring COVID-19 Variants | WIESBADEN, Germany, Aug. 16, 2021 /PRNewswire/ -- InferVision AI has been selected to help monitor COVID-19 variants across the European Union. Faced with this challenge, the European Commission decided to increase their investment in the a... |
| 14.08.2021 | InferVision Closes Series D2 Financing Led by Goldman Sachs | InferVision, a Philadelphia, Pennsylvania-based medical artificial intelligence (AI) provider specializing in the clinical application of AI and deep learning technologies, completed its Series D2 financing led by Goldman Sachs Asset Manage... |
| 13.08.2021 | InferVision Completes Series D2 Financing Round Led by Goldman Sachs Asset Management | InferVision, a medical artificial intelligence (AI) provider specializing in the clinical application of AI and deep learning technologies announced the completion of its Series D2 financing led by Goldman Sachs Asset Management. The compan... |
| 31.07.2021 | AI medtech startup InferVision raises USD 139 million in Series D for predictive medicine | - |
| 25.07.2021 | AI medtech startup InferVision raises USD 139 million in Series D for predictive medicine | Beijing-based medical AI company InferVision completed a Series D round worth RMB 900 million (USD 139 million) from investors including Goldman Sachs, Z-Park Fund, and CCB Trust. The funds will go towards research and development as well a... |
| 23.07.2021 | Qiming’s Springhill backs AI medical imaging startup Infervision’s $139m Series D round | Infervision, a Chinese startup that offers artificial intelligence (AI)-based medical imaging solutions, has closed a new investment that brings the firm’s total capital raise in its Series D round to nearly 900 million yuan ($139 million).... |
| 23.07.2021 | Qiming’s Springhill backs AI medical imaging startup Infervision’s $139m Series D round | Premium Infervision, a Chinese startup that offers artificial intelligence (AI)-based medical imaging solutions, has closed a new investment that brings the firm’s total capital raise in its Series D round to nearly 900 million yuan ($139 m... |
| 07.12.2019 | Africa Tech News Roundup | Seasons Greetings Its the yuletide season. We are glad you made it through the past month. Welcome to the Africa Tech News Roundup. Pick a convenient position and Let’s do this! In the news; The Nigeria Government has signed a new agreement... |
| 04.12.2019 | Ethiopia Government Partners Infervision to Build National Intelligence Infrastructure | The Ethiopia government has partnered Chinese Company Infervision to build a national Artificial Intelligence Infrastructure in the country. Sisay Tola and Chen Kuan signed the agreement. The Ethiopian Minister of Innovation and Technology ... |
Show more